Literature DB >> 19557734

Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas.

Jeong-Sik Yu1, Joo Hee Kim, Jae-Joon Chung, Ki Whang Kim.   

Abstract

PURPOSE: To investigate the additional value of diffusion-weighted imaging (DWI) in the MRI assessment of perilesionally recurrent hepatocellular carcinomas (HCCs) after transcatheter arterial chemoembolization (TACE).
MATERIALS AND METHODS: For gadopentetate dimeglumine-enhanced multiphasic dynamic images with precontrast T1- and T2-weighted images of 23 patients treated with TACE, two radiologists independently sorted the confidence levels for the presence of a viable tumor in the vicinity of the treated lesions into five grades. In another session, images from DWI (b factor = 50, 400, and 800 s/mm(2)) were added to the previously reviewed images and the same radiologists sorted the confidence levels.
RESULTS: A total of 26 lesions (0.7-3.5 cm) from 16 patients were confirmed to be perilesional recurrences of HCC. The area under the receiver operating characteristic curve (A(z)) for the second interpretation session (0.826) was not significantly different (P = 0.299) from that of the first session (0.859). The overall sensitivity was increased from 85% to 92%, but the specificity decreased from 65% to 50% after adding DWI.
CONCLUSION: The addition of DWI has the potential to improve sensitivity, but not the overall diagnostic accuracy, in the assessment of perilesional recurrence of HCCs after chemoembolization. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19557734     DOI: 10.1002/jmri.21818

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  16 in total

Review 1.  Diffusion weighted imaging in the liver.

Authors:  Petra G Kele; Eric J van der Jagt
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

Review 2.  Radiological Response to the Locoregional Treatment in Hepatocellular Carcinoma: RECIST, mRECIST, and Others.

Authors:  Mecit Kantarci; Berhan Pirimoglu
Journal:  J Gastrointest Cancer       Date:  2017-09

3.  Pathological and MR-DWI study of the acute hepatic injury model after stem cell transplantation.

Authors:  Quan-Liang Shang; En-Hua Xiao; Qi-Chang Zhou; Jian-Guang Luo; Hai-Jun Wu
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

4.  Abdominal applications of diffusion-weighted magnetic resonance imaging: Where do we stand.

Authors:  Ajaykumar C Morani; Khaled M Elsayes; Peter S Liu; William J Weadock; Janio Szklaruk; Jonathan Russell Dillman; Asra Khan; Thomas L Chenevert; Hero K Hussain
Journal:  World J Radiol       Date:  2013-03-28

Review 5.  Predicting and monitoring cancer treatment response with diffusion-weighted MRI.

Authors:  Harriet C Thoeny; Brian D Ross
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

Review 6.  Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Ke Yang; Xiao-Ming Zhang; Lin Yang; Hao Xu; Juan Peng
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

Review 7.  Prognostication and response assessment in liver and pancreatic tumors: The new imaging.

Authors:  Riccardo De Robertis; Paolo Tinazzi Martini; Emanuele Demozzi; Gino Puntel; Silvia Ortolani; Sara Cingarlini; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Claudio Bassi; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 8.  Diffusion MRI in early cancer therapeutic response assessment.

Authors:  C J Galbán; B A Hoff; T L Chenevert; B D Ross
Journal:  NMR Biomed       Date:  2016-01-15       Impact factor: 4.044

9.  MRI of Focal Liver Lesions.

Authors:  Nils Albiin
Journal:  Curr Med Imaging Rev       Date:  2012-05

Review 10.  Therapy response with diffusion MRI: an update.

Authors:  Lauren J Bains; Martin Zweifel; Harriet C Thoeny
Journal:  Cancer Imaging       Date:  2012-09-28       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.